Insights in the autoimmunity of myasthenia gravis

Autoimmunity

Volumn 43, Issue 5-6, 2010, Pages 341-343

  De Baets, Marc H ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

acetylcholine receptor; autoimmunity; muscle specific tyrosine kinase; Myasthenia gravis; neuromuscular

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; ENZYME ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G4; MUSCLE SPECIFIC KINASE ANTIBODY; MYCOPHENOLIC ACID; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ANTIBODY; PREDNISONE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; COMPLEMENT CLASSICAL PATHWAY; CYTOTOXICITY; DENDRITIC CELL; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; IMMUNOADSORBENT; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; PATHOGENESIS; PHENOTYPE; PLASMAPHERESIS; POSTSYNAPTIC MEMBRANE; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMECTOMY; THYMOMA; THYMUS; THYMUS HYPERPLASIA;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; HUMANS; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; SYNAPTIC TRANSMISSION; THYMUS GLAND;

EID: 77955911181     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916931003592307     Document Type: Review

References (13)

1. Latif R, Morshed SA, Zaidi M, Davies TF. The thyroidstimulating hormone receptor: Impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metabol Clin N Amer 2009;38(2):319-341.
2. Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine (Baltimore) 2009;88(3):141-153.
3. Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev 2008;22(1):1-15.
4. Verschuuren JJ, Palace J, Gilhus NE. Clinical aspects explained. Autoimmunity 2010;43(5):344-352.
5. Gomez J, Van den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Mart́nez-Mart́nez P, De Baets MH, Losen M. Antibody effector mechanisms in myasthenia gravis - Pathogenesis at the neuromuscular junction. Autoimmunity 2010;43(5):353-370.
6. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976;26(11):1054-1059.
7. Leite MI, Waters P, Vincent A. Diagnostic use of auto-antibodies in myasthenia gravis. Autoimmunity 2010; 43(5):371-379.
8. Vrolix K, Fraussen J, Molenaar PC, Losen M, Somers V, Stinissen P, De Baets MH, Mart́nez-Mart́nez P. The autoantigen repertoire in myasthenia gravis. Autoimmunity 2010; 43(5):380-400.
9. Le Panse R, Bismuth J, Cizeron-Clairac G, Weiss JM, Cufi P, Dartevelle P, Kerlero De Rosbo N, Berrih-Aknin S. Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 2010;43(5):401-412.
10. Marx A, Willcox N, Leite MI, Chuang W, Schalke B, Nix W, Ströbel P. Thymoma and paraneoplastic myasthenia gravis. Autoimmunity 2010;43(5):413-427.
11. Sanders DB, Evoli A. Immunosuppressive therapies in myasthenia gravis Autoimmunity 2010;43(5):428-435.
12. Lagoumintzis G, Zisimopoulou P, Kordas G, Lazaridis K, Poulas K, Tzartos SJ. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis. Autoimmunity 2010;43(5):436-445.
13. Souroujon MC, Brenner T, Fuchs S. Development of novel therapies for MG: Studies in animal models. Autoimmunity 2010;43(5):446-460.